2024 Healthcare Private Equity Outlook and Considerations

The healthcare sector is anticipated to remain an attractive investment for private equity and healthcare companies in 2024. Media reports anticipate a strong investment market across the life sciences, including transactions involving specific drug compounds and patented molecules, as well as ancillary businesses such as device and pharmaceutical manufacturers. Based on recent activity in the space, Kirkland & Ellis also expects an increased interest in platforms providing value-based care as well as health IT platforms utilizing artificial intelligence to streamline and improve the provision of healthcare, as well as back-office functions for healthcare companies.

Read the full article: 2024 Healthcare Private Equity Outlook and Considerations //

Source: https://www.kirkland.com/publications/kirkland-alert/2024/01/2024-healthcare-private-equity-outlook-and-considerations

Leave a Comment

Your email address will not be published.

Scroll to Top